Public recall detail

Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc

medium
Recall Safety notice
Quick summary

Quick summary: Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc .

Official details

Affected product details

Detailed identifiers are not available here. Review the official notice before deciding whether your product is affected.

Brand
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...